{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:41:30Z","timestamp":1787064090108,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF) of Korea","doi-asserted-by":"crossref","award":["2012R1A1A2043237"],"award-info":[{"award-number":["2012R1A1A2043237"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation (NRF) of Korea","doi-asserted-by":"crossref","award":["2015R1D1A1A01060061"],"award-info":[{"award-number":["2015R1D1A1A01060061"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s00280-016-3110-y","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T04:19:00Z","timestamp":1471407540000},"page":"753-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Silencing of fused toes homolog enhances cisplatin sensitivity in cervical cancer cells by inhibiting epidermal growth factor receptor-mediated repair of DNA damage"],"prefix":"10.1007","volume":"78","author":[{"given":"Prabakaran D.","family":"Subramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhe","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Yoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"issue":"2","key":"3110_CR1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbcan.2010.07.004","volume":"1806","author":"B Koberle","year":"2010","unstructured":"Koberle B, Tomicic MT, Usanova S, Kaina B (2010) Cisplatin resistance: preclinical findings and clinical implications. Biochim Biophys Acta Rev Cancer 1806(2):172\u2013182","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"2","key":"3110_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/annonc\/mdi057","volume":"16","author":"JP Spano","year":"2005","unstructured":"Spano JP, Fagard R, Soria JC, Rixe O, Khayat D, Milano G (2005) Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives. Ann Oncol 16(2):189\u2013194","journal-title":"Ann Oncol"},{"issue":"2","key":"3110_CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2010.09.043","volume":"79","author":"MG Noordhuis","year":"2011","unstructured":"Noordhuis MG, Eijsink JJ, Roossink F, de Graeff P, Pras E, Schuuring E, Wisman GB, de Bock GH, van der Zee AG (2011) Prognostic cell biological markers in cervical cancer patients primarily treated with (chemo)radiation: a systematic review. Int J Radiat Oncol Biol Phys 79(2):325\u2013334","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"35","key":"3110_CR4","doi-asserted-by":"crossref","first-page":"31182","DOI":"10.1074\/jbc.M506591200","volume":"280","author":"K Dittmann","year":"2005","unstructured":"Dittmann K, Mayer C, Fehrenbacher B, Schaller M, Raju U, Milas L, Chen DJ, Kehlbach R, Rodemann HP (2005) Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J Biol Chem 280(35):31182\u201331189","journal-title":"J Biol Chem"},{"issue":"9","key":"3110_CR5","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/febs.12226","volume":"280","author":"L Ma","year":"2013","unstructured":"Ma L, Zhang G, Miao XB, Deng XB, Wu Y, Liu Y, Jin ZR, Li XQ, Liu QZ, Sun DX, Testa JR, Yao KT, Xiao GH (2013) Cancer stem-like cell properties are regulated by EGFR\/AKT\/\u03b2-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma. FEBS J 280(9):2027\u20132041","journal-title":"FEBS J"},{"issue":"21","key":"3110_CR6","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1158\/1078-0432.CCR-10-0020","volume":"16","author":"HH Wu","year":"2010","unstructured":"Wu HH, Wu JY, Cheng YW, Chen CY, Lee MC, Goan YG, Lee H (2010) cIAP2 upregulated by E6 oncoprotein via epidermal growth factor receptor\/phosphatidylinositol 3-kinase\/AKT pathway confers resistance to cisplatin in human papillomavirus 16\/18-infected lung cancer. Clin Cancer Res 16(21):5200\u20135210","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3110_CR7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/0008-5472.CAN-10-2384","volume":"71","author":"G Liccardi","year":"2011","unstructured":"Liccardi G, Hartley JA, Hochhauser D (2011) EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment. Cancer Res 71(3):1103\u20131114","journal-title":"Cancer Res"},{"issue":"57","key":"3110_CR8","doi-asserted-by":"crossref","first-page":"8723","DOI":"10.1038\/sj.onc.1205980","volume":"21","author":"M Benhar","year":"2002","unstructured":"Benhar M, Engelberg D, Levitzki A (2002) Cisplatin-induced activation of the EGF receptor. Oncogene 21(57):8723\u20138731","journal-title":"Oncogene"},{"issue":"3","key":"3110_CR9","first-page":"249","volume":"1","author":"SC Hsu","year":"2009","unstructured":"Hsu SC, Miller SA, Wang Y, Hung MC (2009) Nuclear EGFR is required for cisplatin resistance and DNA repair. Am J Transl Res 1(3):249\u2013258","journal-title":"Am J Transl Res"},{"issue":"12","key":"3110_CR10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s003359900604","volume":"8","author":"R Lesche","year":"1997","unstructured":"Lesche R, Peetz A, van der Hoeven F, R\u00fcther U (1997) Ft1, a novel gene related to ubiquitin-conjugating enzymes, is deleted in the Fused toes mouse mutation. Mamm Genome 8(12):879\u2013883","journal-title":"Mamm Genome"},{"issue":"4","key":"3110_CR11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1128\/MCB.24.4.1493-1504.2004","volume":"24","author":"I Remy","year":"2004","unstructured":"Remy I, Michnick SW (2004) Regulation of apoptosis by the Ft1 protein, a new modulator of protein kinase B\/Akt. Mol Cell Biol 24(4):1493\u20131504","journal-title":"Mol Cell Biol"},{"issue":"12","key":"3110_CR12","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1091\/mbc.E08-05-0473","volume":"19","author":"L Xu","year":"2008","unstructured":"Xu L, Sowa ME, Chen J, Li X, Gygi SP, Harper JW (2008) An FTS\/Hook\/p107 (FHIP) complex interacts with and promotes endosomal clustering by the homotypic vacuolar protein sorting complex. Mol Biol Cell 19(12):5059\u20135071","journal-title":"Mol Biol Cell"},{"issue":"6","key":"3110_CR13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/jcp.22486","volume":"226","author":"S Cinghu","year":"2011","unstructured":"Cinghu S, Anandharaj A, Lee HC, Yu JR, Park WY (2011) FTS (fused toes homolog) a novel oncoprotein involved in uterine cervical carcinogenesis and a potential diagnostic marker for cervical cancer. J Cell Physiol 226(6):1564\u20131572","journal-title":"J Cell Physiol"},{"issue":"8","key":"3110_CR14","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1007\/s11033-011-0688-3","volume":"38","author":"A Anandharaj","year":"2011","unstructured":"Anandharaj A, Cinghu S, Kim WD, Yu JR, Park WY (2011) Fused Toes Homolog modulates radiation cytotoxicity in uterine cervical cancer cells. Mol Biol Rep 38(8):5361\u20135370","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3110_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00432-014-1802-4","volume":"141","author":"S Muthusami","year":"2015","unstructured":"Muthusami S, Prabakaran DS, Yu JR, Park WY (2015) FTS is responsible for radiation-induced nuclear phosphorylation of EGFR and repair of DNA damage in cervical cancer cells. J Cancer Res Clin Oncol 141(2):203\u2013210","journal-title":"J Cancer Res Clin Oncol"},{"issue":"10","key":"3110_CR16","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdq723","volume":"22","author":"T Soonthornthum","year":"2011","unstructured":"Soonthornthum T, Arias-Pulido H, Joste N, Lomo L, Muller C, Rutledge T, Verschraegen C (2011) Epidermal growth factor receptor as a biomarker for cervical cancer. Ann Oncol 22(10):2166\u20132178","journal-title":"Ann Oncol"},{"issue":"1","key":"3110_CR17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12253-008-9020-5","volume":"14","author":"Y Hiraishi","year":"2008","unstructured":"Hiraishi Y, Wada T, Nakatani K, Tojyo I, Matsumoto T, Kiga N, Negoro K, Fujita S (2008) EGFR inhibitor enhances cisplatin sensitivity of oral squamous cell carcinoma cell lines. Pathol Oncol Res 14(1):39\u201343","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"3110_CR18","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1158\/1078-0432.CCR-04-0993","volume":"11","author":"Q Dai","year":"2005","unstructured":"Dai Q, Ling YH, Lia M, Zou YY, Kroog G, Iwata KK, Perez-Soler R (2005) Enhanced sensitivity to the HER1\/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines. Clin Cancer Res 11(4):1572\u20131578","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3110_CR19","doi-asserted-by":"crossref","first-page":"F543","DOI":"10.1152\/ajprenal.00112.2004","volume":"287","author":"I Arany","year":"2004","unstructured":"Arany I, Megyesi JK, Kaneto H, Price PM, Safirstein RL (2004) Cisplatin-induced cell death is EGFR\/src\/ERK signaling dependent in mouse proximal tubule cells. Am J Physiol-Renal Physiol 287(3):F543\u2013F549","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"1","key":"3110_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00066-009-2026-4","volume":"186","author":"K Dittmann","year":"2010","unstructured":"Dittmann K, Mayer C, Rodemann HP (2010) Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function. Strahlenther Onkol 186(1):1\u20136","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"3110_CR21","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1074\/jbc.273.3.1568","volume":"273","author":"D Bandyopadhyay","year":"1998","unstructured":"Bandyopadhyay D, Mandal M, Adam L, Mendelsohn J, Kumar R (1998) Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells. J Biol Chem 273(3):1568\u20131573","journal-title":"J Biol Chem"},{"issue":"2","key":"3110_CR22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.06.022","volume":"76","author":"K Dittmann","year":"2005","unstructured":"Dittmann K, Mayer C, Rodemann HP (2005) Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity. Radiother Oncol 76(2):157\u2013161","journal-title":"Radiother Oncol"},{"issue":"10","key":"3110_CR23","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1158\/1541-7786.MCR-12-0482-T","volume":"10","author":"P Javvadi","year":"2012","unstructured":"Javvadi P, Makino H, Das AK, Lin Y-F, Chen DJ, Chen BP, Nirodi CS (2012) Threonine 2609 phosphorylation of the DNA-dependent protein kinase is a critical prerequisite for epidermal growth factor receptor-mediated radiation resistance. Mol Cancer Res 10(10):1359\u20131368","journal-title":"Mol Cancer Res"},{"issue":"2","key":"3110_CR24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0006-2952(02)01508-3","volume":"65","author":"M Crul","year":"2003","unstructured":"Crul M, van Waardenburg RC, Bocxe S, van Eijndhoven MA, Pluim D, Beijnen JH, Schellens JH (2003) DNA repair mechanisms involved in gemcitabine cytotoxicity and in the interaction between gemcitabine and cisplatin. Biochem Pharmacol 65(2):275\u2013282","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"3110_CR25","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cyto.a.20018","volume":"58","author":"X Huang","year":"2004","unstructured":"Huang X, Okafuji M, Traganos F, Luther E, Holden E, Darzynkiewicz Z (2004) Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin. Cytom Part A 58(2):99\u2013110","journal-title":"Cytom Part A"},{"issue":"2","key":"3110_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2011.01.030","volume":"121","author":"J Farley","year":"2011","unstructured":"Farley J, Sill MW, Birrer M, Walker J, Schilder RJ, Thigpen JT, Coleman RL, Miller BE, Rose PG, Lankes HA (2011) Phase II study of cisplatin plus cetuximab in advanced, recurrent, and previously treated cancers of the cervix and evaluation of epidermal growth factor receptor immunohistochemical expression: a Gynecologic Oncology Group study. Gynecol Oncol 121(2):303\u2013308","journal-title":"Gynecol Oncol"},{"issue":"3","key":"3110_CR27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2011.05.040","volume":"122","author":"AD Santin","year":"2011","unstructured":"Santin AD, Sill MW, McMeekin DS, Leitao MM Jr, Brown J, Sutton GP, Van Le L, Griffin P, Boardman CH (2011) Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 122(3):495\u2013500","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3110_CR28","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/IGC.0b013e3181a83467","volume":"19","author":"RJ Schilder","year":"2009","unstructured":"Schilder RJ, Sill MW, Lee YC, Mannel R (2009) A phase II trial of erlotinib in recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Int J Gynecol Cancer 19(5):929\u2013933","journal-title":"Int J Gynecol Cancer"},{"issue":"10","key":"3110_CR29","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1007\/s11033-013-2660-x","volume":"40","author":"S Muthusami","year":"2013","unstructured":"Muthusami S, Prabakaran DS, An Z, Yu JR, Park WY (2013) EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells. Mol Biol Rep 40(10):5587\u20135596","journal-title":"Mol Biol Rep"},{"issue":"2","key":"3110_CR30","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2014.06.007","volume":"351","author":"S Muthusami","year":"2014","unstructured":"Muthusami S, Prabakaran DS, Yu JR, Park WY (2014) EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells. Cancer Lett 351(2):252\u2013259","journal-title":"Cancer Lett"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3110-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3110-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:50:56Z","timestamp":1498323056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3110-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["3110"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3110-y","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}